{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:34:57Z","timestamp":1791513297251,"version":"4.3.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["TTK22031652"],"award-info":[{"award-number":["TTK22031652"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["23\/84"],"award-info":[{"award-number":["23\/84"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>HIV-1 disrupts the metabolic profile of people living with HIV (PLWH), including the Tryptophan\u2013Kynurenine (Trp\u2013Kyn) pathway, linked to disease outcomes and comorbidities. Despite numerous studies, consensus on key dysregulated metabolites in antiretroviral therapy (ART)-treated PLWH is lacking. This systematic review compiles data to identify and highlight the most noteworthy Trp\u2013Kyn metabolites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>PubMed, Scopus, and Web of Science databases were searched using a search protocol specifically designed for this study. Studies that investigated the levels of metabolites in the\u00a0Trp\u2013Kyn pathway in the peripheral blood of PLWH on ART, as well as\u00a0in healthy control groups were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirteen metabolomic studies that investigated this pathway met our inclusion criteria. The findings revealed that Trp, Kyn, and the Kyn\/Trp ratio (indicative of indoleamine 2,3-dioxygenase IDO activity) were the most investigated metabolites in this metabolic pathway. Evidence consistently demonstrated that Trp levels were lower in PLWH, while predicted IDO activity was consistently higher. Despite the widespread investigation of Kyn, there was no clear consensus on its levels in PLWH, with some studies reporting higher levels and others finding no significant differences compared to HIV-negative controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In the modern ART era, Trp metabolism and IDO activity may play key regulatory roles in HIV-1 pathogenesis, as evidenced by the consistent patterns observed across various studies. These metabolites and related pathways warrant further investigation as potential targets for improved diagnostics, prognostics, and therapeutics in the context of HIV-1.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s15010-025-02557-1","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T06:56:09Z","timestamp":1748674569000},"page":"1625-1644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Tryptophan-Kynurenine pathway in people living with HIV: a systematic review"],"prefix":"10.1007","volume":"53","author":[{"given":"Tshiamo Will","family":"Sebigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levanco K.","family":"Asia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant G.","family":"January","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esm\u00e9","family":"Jansen van Vuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monray Edward","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"Supplement 2","key":"2557_CR1","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1097\/QAD.0000000000002983","volume":"35","author":"K Heath","year":"2021","unstructured":"Heath K, Levi J, Hill A. The Joint United Nations Programme on HIV\/AIDS 95\u201395\u201395 targets: worldwide clinical and cost benefits of generic manufacture. AIDS. 2021;35(Supplement 2):S197\u2013203.","journal-title":"AIDS"},{"issue":"4","key":"2557_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/rmv.1739","volume":"23","author":"S Nyamweya","year":"2013","unstructured":"Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC. Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev Med Virol. 2013;23(4):221\u201340.","journal-title":"Rev Med Virol"},{"key":"2557_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(18)30254-6","author":"J Esbj\u00f6rnsson","year":"2018","unstructured":"Esbj\u00f6rnsson J, M\u00e5nsson F, Kvist A, da Silva ZJ, Andersson S, Feny\u00f6 EM, et al. Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study. Lancet HIV. 2018. https:\/\/doi.org\/10.1016\/s2352-3018(18)30254-6.","journal-title":"Lancet HIV"},{"issue":"11","key":"2557_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/infdis\/jiad327","volume":"228","author":"A Williams","year":"2023","unstructured":"Williams A, Menon S, Crowe M, Agarwal N, Biccler J, Bbosa N, et al. Geographic and population distributions of human immunodeficiency virus (HIV)\u20131 and HIV-2 circulating subtypes: a systematic literature review and meta-analysis (2010\u20132021). J Infect Dis. 2023;228(11):1583\u201391. https:\/\/doi.org\/10.1093\/infdis\/jiad327.","journal-title":"J Infect Dis"},{"issue":"2","key":"2557_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355. https:\/\/doi.org\/10.1016\/s1473-3099(18)30647-9.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2557_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","volume":"18","author":"J Hemelaar","year":"2012","unstructured":"Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol Med. 2012;18(3):182\u201392.","journal-title":"Trends Mol Med"},{"issue":"2","key":"2557_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355.","journal-title":"Lancet Infect Dis"},{"key":"2557_CR8","doi-asserted-by":"publisher","first-page":"1343361","DOI":"10.3389\/fcvm.2024.1343361","volume":"11","author":"MA Frias","year":"2024","unstructured":"Frias MA, Pagano S, Bararpour N, Sidib\u00e9 J, Kamau F, F\u00e9taud-Lapierre V, et al. People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case\u2013control study. Front Cardiovasc Med. 2024;11:1343361.","journal-title":"Front Cardiovasc Med"},{"key":"2557_CR9","doi-asserted-by":"publisher","first-page":"7316456","DOI":"10.1155\/2021\/7316456","volume":"2021","author":"T Lv","year":"2021","unstructured":"Lv T, Cao W, Li T. HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456. https:\/\/doi.org\/10.1155\/2021\/7316456.","journal-title":"J Immunol Res"},{"issue":"4","key":"2557_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633\u201345. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.001.","journal-title":"Immunity"},{"key":"2557_CR11","doi-asserted-by":"publisher","first-page":"3080969","DOI":"10.1155\/2023\/3080969","volume":"2023","author":"Z Pan","year":"2023","unstructured":"Pan Z, Wu N, Jin C. Intestinal microbiota dysbiosis promotes mucosal barrier damage and immune injury in HIV-infected patients. Can J Infect Dis Med Microbiol. 2023;2023:3080969. https:\/\/doi.org\/10.1155\/2023\/3080969.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"2557_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bmb\/ldy019","volume":"127","author":"K Alford","year":"2018","unstructured":"Alford K, Vera JH. Cognitive Impairment in people living with HIV in the ART era: a review. Br Med Bull. 2018;127(1):55\u201368. https:\/\/doi.org\/10.1093\/bmb\/ldy019.","journal-title":"Br Med Bull"},{"issue":"5","key":"2557_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8059","volume":"12","author":"HE Ergin","year":"2020","unstructured":"Ergin HE, Inga EE, Maung TZ, Javed M, Khan S. HIV, antiretroviral therapy and metabolic alterations: a review. Cureus. 2020;12(5): e8059. https:\/\/doi.org\/10.7759\/cureus.8059.","journal-title":"Cureus"},{"key":"2557_CR14","doi-asserted-by":"publisher","first-page":"6238978","DOI":"10.1155\/2018\/6238978","volume":"2018","author":"D Ahmed","year":"2018","unstructured":"Ahmed D, Roy D, Cassol E. Examining relationships between metabolism and persistent inflammation in HIV patients on antiretroviral therapy. Mediators Inflamm. 2018;2018:6238978. https:\/\/doi.org\/10.1155\/2018\/6238978.","journal-title":"Mediators Inflamm"},{"key":"2557_CR15","doi-asserted-by":"publisher","first-page":"1244622","DOI":"10.3389\/fimmu.2023.1244622","volume":"14","author":"S Sultana","year":"2023","unstructured":"Sultana S, Elengickal A, Bensreti H, Belin de Chantem\u00e8le E, McGee-Lawrence ME, Hamrick MW. The kynurenine pathway in HIV, frailty and inflammaging. Front Immunol. 2023;14:1244622. https:\/\/doi.org\/10.3389\/fimmu.2023.1244622.","journal-title":"Front Immunol"},{"issue":"2","key":"2557_CR16","first-page":"96","volume":"17","author":"J-P Routy","year":"2015","unstructured":"Routy J-P, Mehraj V, Vyboh K, Cao W, Kema I, Jenabian M-A. Clinical relevance of kynurenine pathway in HIV\/AIDS: an immune checkpoint at the crossroads of metabolism and inflammation. AIDS Rev. 2015;17(2):96\u2013106.","journal-title":"AIDS Rev"},{"issue":"193","key":"2557_CR17","doi-asserted-by":"publisher","first-page":"193ea91","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ea91. https:\/\/doi.org\/10.1126\/scitranslmed.3006438.","journal-title":"Sci Transl Med."},{"issue":"8","key":"2557_CR18","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35(8):1304\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004.","journal-title":"Cell Metab"},{"key":"2557_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41043-016-0042-4","volume":"35","author":"P Bipath","year":"2016","unstructured":"Bipath P, Levay PF, Viljoen M. Tryptophan depletion in context of the inflammatory and general nutritional status of a low-income South African HIV-infected population. J Health Popul Nutr. 2016;35:1\u20137.","journal-title":"J Health Popul Nutr"},{"issue":"2","key":"2557_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192169","volume":"13","author":"MH Christensen","year":"2018","unstructured":"Christensen MH, Fadnes DJ, R\u00f8st TH, Pedersen ER, Andersen JR, V\u00e5ge V, et al. Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery. PLoS ONE. 2018;13(2): e0192169.","journal-title":"PLoS ONE"},{"key":"2557_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jmsacl.2023.04.003","volume":"28","author":"S Abusoglu","year":"2023","unstructured":"Abusoglu S, Onmaz DE, Abusoglu G, Yerlikaya FH, Unlu A. Measurement of kynurenine pathway metabolites by tandem mass spectrometry. J Mass Spectrom Adv Clin Lab. 2023;28:114\u201321.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"2557_CR22","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. 2017;10:1178646917691938.","journal-title":"Int J Tryptophan Res"},{"issue":"3","key":"2557_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","volume":"41","author":"HJ Ball","year":"2009","unstructured":"Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH. Indoleamine 2, 3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 2009;41(3):467\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"2557_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.897929","volume":"9","author":"S Klaessens","year":"2022","unstructured":"Klaessens S, Stroobant V, De Plaen E, Van den Eynde BJ. Systemic tryptophan homeostasis. Front Mol Biosci. 2022;9: 897929.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"2557_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/vaccines3030703","volume":"3","author":"JC Mbongue","year":"2015","unstructured":"Mbongue JC, Nicholas DA, Torrez TW, Kim NS, Firek AF, Langridge WH. The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines (Basel). 2015;3(3):703\u201329. https:\/\/doi.org\/10.3390\/vaccines3030703.","journal-title":"Vaccines (Basel)"},{"key":"2557_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2015.00097","author":"JM Gostner","year":"2015","unstructured":"Gostner JM, Becker K, Kurz K, Fuchs D. disturbed amino acid metabolism in hiv: association with neuropsychiatric symptoms. Front Psychiatry. 2015. https:\/\/doi.org\/10.3389\/fpsyt.2015.00097.","journal-title":"Front Psychiatry."},{"issue":"7","key":"2557_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13(7):465\u201377.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2557_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12985-024-02313-1","volume":"21","author":"LK Asia","year":"2024","unstructured":"Asia LK, Van Vuren EJ, Lindeque Z, Williams ME. A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment. Virol J. 2024;21(1):47.","journal-title":"Virol J"},{"issue":"17","key":"2557_CR29","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1128\/JVI.00994-16","volume":"90","author":"X Dagenais-Lussier","year":"2016","unstructured":"Dagenais-Lussier X, Aounallah M, Mehraj V, El-Far M, Tremblay C, Sekaly R-P, et al. Kynurenine reduces memory CD4 T-cell survival by interfering with interleukin-2 signaling early during HIV-1 infection. J Virol. 2016;90(17):7967\u201379.","journal-title":"J Virol"},{"issue":"4","key":"2557_CR30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","volume":"44","author":"M Huengsberg","year":"1998","unstructured":"Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem. 1998;44(4):858\u201362. https:\/\/doi.org\/10.1093\/clinchem\/44.4.858.","journal-title":"Clin Chem"},{"key":"2557_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1244622","author":"S Sultana","year":"2023","unstructured":"Sultana S, Elengickal A, Bensreti H, De Chantem\u00e8le EB, McGee-Lawrence ME, Hamrick MW. The kynurenine pathway in HIV, frailty and inflammaging. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1244622.","journal-title":"Front Immunol"},{"key":"2557_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"BMJ"},{"issue":"6","key":"2557_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050139","volume":"5","author":"I Simera","year":"2008","unstructured":"Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for reporting health research: the EQUATOR network\u2019s survey of guideline authors. PLoS Med. 2008;5(6): e139. https:\/\/doi.org\/10.1371\/journal.pmed.0050139.","journal-title":"PLoS Med"},{"key":"2557_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2055-6640(20)30340-X","volume":"4","author":"D Nash","year":"2018","unstructured":"Nash D, Yotebieng M, Sohn AH. Treating all people living with HIV in sub-Saharan Africa: a new era calling for new approaches. J Virus Eradic. 2018;4:1\u20134. https:\/\/doi.org\/10.1016\/S2055-6640(20)30340-X.","journal-title":"J Virus Eradic"},{"key":"2557_CR35","doi-asserted-by":"publisher","first-page":"117864692412482","DOI":"10.1177\/11786469241248287","volume":"17","author":"BS Summers","year":"2024","unstructured":"Summers BS, Thomas Broome S, Pang TWR, Mundell HD, Koh Belic N, Tom NC, et al. A review of the evidence for tryptophan and the kynurenine pathway as a regulator of stem cell niches in health and disease. Int J Tryptophan Res. 2024;17:11786469241248288.","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"2557_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12879-024-09258-4","volume":"24","author":"S Gatechompol","year":"2024","unstructured":"Gatechompol S, Lutter R, Vaz FM, Ubolyam S, Avihingsanon A, Kerr SJ, et al. The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case\u2013control study. BMC Infect Dis. 2024;24(1):372.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2557_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12874-017-0347-z","volume":"17","author":"L Hartling","year":"2017","unstructured":"Hartling L, Featherstone R, Nuspl M, Shave K, Dryden DM, Vandermeer B. Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews. BMC Med Res Methodol. 2017;17(1):64. https:\/\/doi.org\/10.1186\/s12874-017-0347-z.","journal-title":"BMC Med Res Methodol"},{"key":"2557_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jclinepi.2019.10.011","volume":"118","author":"B Nussbaumer-Streit","year":"2020","unstructured":"Nussbaumer-Streit B, Klerings I, Dobrescu AI, Persad E, Stevens A, Garritty C, et al. Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. J Clin Epidemiol. 2020;118:42\u201354. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.10.011.","journal-title":"J Clin Epidemiol"},{"issue":"140","key":"2557_CR39","first-page":"55","volume":"22","author":"R Likert","year":"1932","unstructured":"Likert R. A technique for the measurement of attitudes. Archives of Psychology. 1932;22(140):55.","journal-title":"Archives of Psychology."},{"issue":"3","key":"2557_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jnc.15295","volume":"157","author":"ME Williams","year":"2021","unstructured":"Williams ME, Naud\u00e9 PJW, van der Westhuizen FH. Proteomics and metabolomics of HIV-associated neurocognitive disorders: a systematic review. J Neurochem. 2021;157(3):429\u201349. https:\/\/doi.org\/10.1111\/jnc.15295.","journal-title":"J Neurochem"},{"issue":"1","key":"2557_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2519","volume":"34","author":"ME Williams","year":"2024","unstructured":"Williams ME, Naud\u00e9 PJ. The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: a systematic review of studies investigating post-mortem brain tissue. Rev Med Virol. 2024;34(1): e2519.","journal-title":"Rev Med Virol"},{"issue":"1","key":"2557_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12879-023-08123-0","volume":"23","author":"PT Gotora","year":"2023","unstructured":"Gotora PT, van der Sluis R, Williams ME. HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review. BMC Infect Dis. 2023;23(1):164. https:\/\/doi.org\/10.1186\/s12879-023-08123-0.","journal-title":"BMC Infect Dis"},{"key":"2557_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13943","author":"LK Asia","year":"2022","unstructured":"Asia LK, Jansen Van Vuren E, Williams ME. The influence of viral protein R amino acid substitutions on clinical outcomes in people living with HIV: a systematic review. Eur J Clin Invest. 2022. https:\/\/doi.org\/10.1111\/eci.13943.","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"2557_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161920","volume":"11","author":"B Scarpellini","year":"2016","unstructured":"Scarpellini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, Segurado ID, et al. Plasma metabolomics biosignature according to HIV stage of infection, pace of disease progression, viremia level and immunological response to treatment. PLoS ONE. 2016;11(12): e0161920. https:\/\/doi.org\/10.1371\/journal.pone.0161920.","journal-title":"PLoS ONE"},{"issue":"5","key":"2557_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/qad.0000000000001730","volume":"32","author":"E Rodr\u00edguez-Gallego","year":"2018","unstructured":"Rodr\u00edguez-Gallego E, G\u00f3mez J, Pacheco YM, Peraire J, Vilad\u00e9s C, Beltr\u00e1n-Deb\u00f3n R, et al. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients. AIDS. 2018;32(5):565\u201373. https:\/\/doi.org\/10.1097\/qad.0000000000001730.","journal-title":"AIDS"},{"issue":"1","key":"2557_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13104-016-1953-2","volume":"9","author":"AT Hirigo","year":"2016","unstructured":"Hirigo AT, Tesfaye DY. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia. BMC Res Notes. 2016;9(1):145. https:\/\/doi.org\/10.1186\/s13104-016-1953-2.","journal-title":"BMC Res Notes"},{"key":"2557_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104701","volume":"136","author":"ME Williams","year":"2020","unstructured":"Williams ME, Zulu SS, Stein DJ, Joska JA, Naud\u00e9 PJW. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments. Neurobiol Dis. 2020;136: 104701. https:\/\/doi.org\/10.1016\/j.nbd.2019.104701.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2557_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2989\/16085906.2021.1998783","volume":"20","author":"IJK Biney","year":"2021","unstructured":"Biney IJK, Kyei KA, Ganu VJ, Kenu E, Puplampu P, Manortey S, et al. Antiretroviral therapy adherence and viral suppression among HIV-infected adolescents and young adults at a tertiary hospital in Ghana. Afr J AIDS Res. 2021;20(4):270\u20136. https:\/\/doi.org\/10.2989\/16085906.2021.1998783.","journal-title":"Afr J AIDS Res"},{"issue":"1","key":"2557_CR49","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1186\/s12879-021-06608-4","volume":"21","author":"G Gabagaya","year":"2021","unstructured":"Gabagaya G, Rukundo G, Amone A, Wavamunno P, Namale-Matovu J, Lubega I, et al. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial. BMC Infect Dis. 2021;21(1):907. https:\/\/doi.org\/10.1186\/s12879-021-06608-4.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2557_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7196\/SAMJ.2019.v109i3.13456","volume":"109","author":"J Euvrard","year":"2019","unstructured":"Euvrard J, Schulz T, Hilderbrand K, Bosland M, Osler M, Boulle A, et al. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90\u201390-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa? S Afr Med J. 2019;109(3):174\u20137. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i3.13456.","journal-title":"S Afr Med J"},{"issue":"1","key":"2557_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12985-024-02313-1","volume":"21","author":"LK Asia","year":"2024","unstructured":"Asia LK, Van Vuren EJ, Lindeque Z, Williams ME. A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment. Virol J. 2024;21(1):47. https:\/\/doi.org\/10.1186\/s12985-024-02313-1.","journal-title":"Virol J"},{"key":"2557_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9100210","author":"H Babu","year":"2019","unstructured":"Babu H, Sperk M, Ambikan AT, Rachel G, Viswanathan VK, Tripathy SP, et al. Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy. Metabolites. 2019. https:\/\/doi.org\/10.3390\/metabo9100210.","journal-title":"Metabolites"},{"issue":"7","key":"2557_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100446","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen J, Shao J, Cai R, Shen Y, Zhang R, Liu L, et al. Anti-retroviral therapy decreases but does not normalize indoleamine 2, 3-dioxygenase activity in HIV-infected patients. PLoS ONE. 2014;9(7): e100446.","journal-title":"PLoS ONE"},{"issue":"8","key":"2557_CR54","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cid\/ciy676","volume":"68","author":"J Chen","year":"2019","unstructured":"Chen J, Xun J, Yang J, Ji Y, Liu L, Qi T, et al. Plasma indoleamine 2, 3-dioxygenase activity is associated with the size of the human immunodeficiency virus reservoir in patients receiving antiretroviral therapy. Clin Infect Dis. 2019;68(8):1274\u201381.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2557_CR55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0165-2478(91)90005-U","volume":"28","author":"D Fuchs","year":"1991","unstructured":"Fuchs D, M\u00f6ller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett. 1991;28(3):207\u201311.","journal-title":"Immunol Lett"},{"issue":"10","key":"2557_CR56","doi-asserted-by":"publisher","first-page":"e78146","DOI":"10.1371\/journal.pone.0078146","volume":"8","author":"MA Jenabian","year":"2013","unstructured":"Jenabian M-A, Patel M, Kema I, Kanagaratham C, Radzioch D, Thebault P, et al. Distinct tryptophan catabolism and Th17\/Treg balance in HIV progressors and elite controllers. PloS one. 2013;8(10):e78146","journal-title":"PloS one"},{"key":"2557_CR57","doi-asserted-by":"publisher","unstructured":"Li X, Wu T, Jiang Y, Zhang Z, Han X, Geng W, et al. Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir\/ritonavir based treatment: Implications for HIV precision therapy. Cytokine. 2018;110:204-12.\nhttps:\/\/doi.org\/10.1016\/j.cyto.2018.05.001","DOI":"10.1016\/j.cyto.2018.05.001"},{"key":"2557_CR58","doi-asserted-by":"publisher","first-page":"112796","DOI":"10.1016\/j.jpba.2019.112796","volume":"176","author":"LJ Sitole","year":"2019","unstructured":"Sitole LJ, Tugizimana F, Meyer D. Multi-platform metabonomics unravel amino acids as markers of HIV\/combination antiretroviral therapy-induced oxidative stress. J Pharma Biomed Anal. 2019;176:112796","journal-title":"J Pharma Biomed Anal"},{"issue":"1","key":"2557_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","volume":"29","author":"M Somsouk","year":"2015","unstructured":"Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM, et al. Gut epithelial barrier and systemicinflammation during chronic HIV infection. Aids. 2015;29(1):43\u201351.","journal-title":"Aids."},{"key":"2557_CR60","doi-asserted-by":"crossref","unstructured":"Yang J, Cai R, Xun J, Zhang R, Liu L, Shen Y, et al. Elevated indoleamine 2, 3-dioxygenase activity is associated with endothelial dysfunction in people living with HIV and ROS production in human aortic endothelial cells in vitro. Drug Discov Ther. 2023;17(5):312-9","DOI":"10.5582\/ddt.2023.01069"},{"issue":"1","key":"2557_CR61","doi-asserted-by":"publisher","first-page":"e24795","DOI":"10.1002\/jcla.24795","volume":"37","author":"ZW Yuan","year":"2023","unstructured":"Yuan ZW, Gan HL, Jin HL, Feng XY, Wang M, Zhou HP, et al. Evaluation of characteristic metabolites of aromatic amino acids in patients with HIV infection at different stages of disease. J Clin Lab Anal. 2023;37(1):e24795","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"2557_CR62","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/qad.0000000000003512","volume":"37","author":"S Svensson Akusj\u00e4rvi","year":"2023","unstructured":"Svensson Akusj\u00e4rvi S, Krishnan S, Ambikan AT, Mikaeloff F, Munusamy Ponnan S, Vesterbacka J, et al. Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment. AIDS. 2023;37(7):1023\u201333. https:\/\/doi.org\/10.1097\/qad.0000000000003512.","journal-title":"AIDS"},{"key":"2557_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cyto.2018.05.001","volume":"110","author":"X Li","year":"2018","unstructured":"Li X, Wu T, Jiang Y, Zhang Z, Han X, Geng W, et al. Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir\/ritonavir based treatment: Implications for HIV precision therapy. Cytokine. 2018;110:204\u201312. https:\/\/doi.org\/10.1016\/j.cyto.2018.05.001.","journal-title":"Cytokine"},{"key":"2557_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577649","volume":"358","author":"ME Williams","year":"2021","unstructured":"Williams ME, Stein DJ, Joska JA, Naud\u00e9 PJW. Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: a systematic review. J Neuroimmunol. 2021;358: 577649. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577649.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"2557_CR65","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00726-023-03325-x","volume":"55","author":"J Zhang","year":"2023","unstructured":"Zhang J, Chen Y, Wang M, Zhong L, Li L, Yuan Z, et al. Amino acid metabolism dysregulation associated with inflammation and insulin resistance in HIV-infected individuals with metabolic disorders. Amino Acids. 2023;55(11):1545\u201355.","journal-title":"Amino Acids"},{"key":"2557_CR66","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AAB Badawy","year":"2017","unstructured":"Badawy AAB. Kynurenine PATHWAY OF TRYPTOPHAN METABOLISM: REGULATORY AND FUNCTIONAL ASPECTS. Int J Tryptophan Res. 2017;10:117864691769193. https:\/\/doi.org\/10.1177\/1178646917691938.","journal-title":"Int J Tryptophan Res"},{"key":"2557_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2018.03.007","volume":"319","author":"AM Anderson","year":"2018","unstructured":"Anderson AM, Croteau D, Ellis RJ, Rosario D, Potter M, Guillemin GJ, et al. HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau. J Neuroimmunol. 2018;319:13\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.03.007.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"2557_CR68","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/j.1742-4658.2012.08500.x","volume":"279","author":"A Kandanearatchi","year":"2012","unstructured":"Kandanearatchi A, Brew BJ. The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders. Febs j. 2012;279(8):1366\u201374. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08500.x.","journal-title":"Febs j"},{"key":"2557_CR69","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","volume":"10","author":"FJ Sorgdrager","year":"2019","unstructured":"Sorgdrager FJ, Naud\u00e9 PJ, Kema IP, Nollen EA, Deyn PPD. Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol. 2019;10:2565.","journal-title":"Front Immunol"},{"key":"2557_CR70","doi-asserted-by":"publisher","first-page":"117864691986897","DOI":"10.1177\/1178646919868978","volume":"12","author":"AA Badawy","year":"2019","unstructured":"Badawy AA, Guillemin G. The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2, 3-dioxygenase: time for appraisal. Int J Tryptophan Res. 2019;12:1178646919868978.","journal-title":"Int J Tryptophan Res"},{"key":"2557_CR71","doi-asserted-by":"publisher","first-page":"117864692412482","DOI":"10.1177\/11786469241248287","volume":"17","author":"BS Summers","year":"2024","unstructured":"Summers BS, Thomas Broome S, Pang TWR, Mundell HD, Koh Belic N, Tom NC, et al. A review of the evidence for tryptophan and the kynurenine pathway as a regulator of stem cell niches in health and disease. Int J Tryptophan Res. 2024;17:11786469241248288. https:\/\/doi.org\/10.1177\/11786469241248287.","journal-title":"Int J Tryptophan Res"},{"issue":"7","key":"2557_CR72","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/qad.0000000000003546","volume":"37","author":"F Guerville","year":"2023","unstructured":"Guerville F, Vialemaringe M, Cognet C, Duffau P, Lazaro E, Cazanave C, et al. Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis. AIDS. 2023;37(7):1035\u201346. https:\/\/doi.org\/10.1097\/qad.0000000000003546.","journal-title":"AIDS"},{"key":"2557_CR73","doi-asserted-by":"publisher","first-page":"117864692312111","DOI":"10.1177\/11786469231211184","volume":"16","author":"N-J Metri","year":"2023","unstructured":"Metri N-J, Butt AS, Murali A, Steiner-Lim GZ, Lim CK. Normative data on serum and plasma tryptophan and kynurenine concentrations from 8089 individuals across 120 studies: a systematic review and meta-analysis. Int J Tryptophan Res. 2023;16:11786469231211184.","journal-title":"Int J Tryptophan Res"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02557-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:41:44Z","timestamp":1758721304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2557"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02557-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}